Research and experimental development on natural sciences and engineering
NORSK BIOKULL AS
Revenue 2024
NOK 14,000
Operating profit
NOK −33,000
Equity
NOK 304,000
Incorporated
2015
Share capital
NOK 605,000
Key figures · 2024
Current ratio
32.61
Equity ratio
99.4%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -227.5% | |
| Net margin (%%) | -221.1% | |
| Return on assets (%%) | -10.7% | |
| Likviditet | ||
| Current ratio | 32.61 | |
| Working capital | 54k | |
| Soliditet | ||
| Equity ratio (%%) | 99.4% | |
| Debt-to-equity ratio | 0.01 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.